Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma: Updated results from the pivotal EPCORE NHL-1 trial
dc.contributor.author | Karimi, Y. | en |
dc.contributor.author | Ghesquieres, H. | en |
dc.contributor.author | Jurczak, W. | en |
dc.contributor.author | Cheah, C. | en |
dc.contributor.author | Clausen, M. | en |
dc.contributor.author | Lugtenburg, P. | en |
dc.contributor.author | Cunningham, D. | en |
dc.contributor.author | Do, Y. R. | en |
dc.contributor.author | Lewis, D. J. | en |
dc.contributor.author | Gasiorowski, R. | en |
dc.contributor.author | Kim, T. M. | en |
dc.contributor.author | Van der Poel, M. | en |
dc.contributor.author | Poon, M. L. M. | en |
dc.contributor.author | Feldman, T. A. | en |
dc.contributor.author | Linton, Kim M | en |
dc.contributor.author | Sureda, A. | en |
dc.contributor.author | Hutchings, M. | en |
dc.contributor.author | Stirner, M. C. | en |
dc.contributor.author | Sacchi, M. | en |
dc.contributor.author | Thieblemont, C. | en |
dc.date.accessioned | 2023-10-25T08:48:36Z | |
dc.date.available | 2023-10-25T08:48:36Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | Karimi Y, Ghesquieres H, Jurczak W, Cheah C, Clausen M, Lugtenburg P, et al. Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma: Updated results from the pivotal EPCORE NHL-1 trial. Journal of Clinical Oncology. 2023 Jun;41(16). PubMed PMID: WOS:001053772003468. | en |
dc.identifier.doi | 10.1200/JCO.2023.41.16_suppl.7525 | en |
dc.identifier.uri | http://hdl.handle.net/10541/626652 | |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1200/JCO.2023.41.16_suppl.7525 | en |
dc.title | Effect of follow-up time on the ability of subcutaneous epcoritamab to induce deep and durable complete remissions in patients with relapsed/refractory large B-cell lymphoma: Updated results from the pivotal EPCORE NHL-1 trial | en |
dc.type | Meetings and Proceedings | en |
dc.contributor.department | University of Michigan Comprehensive Cancer Center, Ann Arbor, MI | en |
dc.identifier.journal | Journal of Clinical Oncology | en |
dc.description.note | en] |